Heterogeneity of Alzheimer's disease. An interpretive review.
Fudenberg
H H
HH
NeuroImmunoTherapeutics Research Foundation, Spartanburg, SC.
D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000188:drug therapy* / Q000276:immunology*; D001379:Azathioprine / Q000627:therapeutic use; D002457:Cell Extracts / Q000627:therapeutic use; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D018697:Nootropic Agents / Q000627:therapeutic use; D010889:Piracetam / Q000627:therapeutic use; D011760:Pyrrolidinones / Q000627:therapeutic use; D016037:Single-Blind Method; D014165:Transfer Factor / Q000627:therapeutic use
D002457:Cell Extracts; D018697:Nootropic Agents; D011760:Pyrrolidinones; D014165:Transfer Factor; C036466:aniracetam; D001379:Azathioprine; D010889:Piracetam